NCT00233935View on ClinicalTrials.gov

Defined Green Tea Catechin Extract in Preventing Esophageal Cancer in Patients With Barrett's Esophagus

PHASE1CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Barrett Esophagus
Interventions
OTHER

placebo

Given PO

DRUG

defined green tea catechin extract

Given PO

Trial Locations (3)

10032

Columbia University Medical Center, New York

10065

Weill Medical College of Cornell University, New York

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00233935 - Defined Green Tea Catechin Extract in Preventing Esophageal Cancer in Patients With Barrett's Esophagus | Biotech Hunter | Biotech Hunter